Global GLP-1 Analogues Market Growth 2026-2032

April 2026 | 91 pages | ID: G0A6F2C88BEBEN
LP Information

Abstracts

The global GLP-1 Analogues market size is predicted to grow from US$ 2961 million in 2025 to US$ 4724 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

GLP-1 analogues are a class of medications used in the treatment of type 2 diabetes. They mimic the effects of glucagon-like peptide 1 (GLP-1), which is a hormone produced by the gut that helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon secretion.

United States market for GLP-1 Analogues is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for GLP-1 Analogues is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for GLP-1 Analogues is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key GLP-1 Analogues players cover Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?GLP-1 Analogues Industry Forecast? looks at past sales and reviews total world GLP-1 Analogues sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 Analogues sales for 2026 through 2032. With GLP-1 Analogues sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Analogues industry.

This Insight Report provides a comprehensive analysis of the global GLP-1 Analogues landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Analogues portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GLP-1 Analogues market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Analogues and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Analogues.

This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Analogues market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Exenatide
• Liraglutide
• Semaglutide
• Dulaglutide
• Other

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• AstraZeneca
• Eli Lily
• GSK
• Sanofi
• Jiangsu Hansoh Pharmaceutical
• Shanghai Benemae Pharmaceutical

Key Questions Addressed in this Report

• What is the 10-year outlook for the global GLP-1 Analogues market?
• What factors are driving GLP-1 Analogues market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do GLP-1 Analogues market opportunities vary by end market size?
• How does GLP-1 Analogues break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global GLP-1 Analogues Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for GLP-1 Analogues by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for GLP-1 Analogues by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 Analogues Segment by Type
  2.2.1 Exenatide
  2.2.2 Liraglutide
  2.2.3 Semaglutide
  2.2.4 Dulaglutide
  2.2.5 Other
  2.2.6 GLP-1 Analogues Sales by Type
    2.2.6.1 Global GLP-1 Analogues Sales Market Share by Type (2021-2026)
    2.2.6.2 Global GLP-1 Analogues Revenue and Market Share by Type (2021-2026)
    2.2.6.3 Global GLP-1 Analogues Sale Price by Type (2021-2026)
2.3 GLP-1 Analogues Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 GLP-1 Analogues Sales by Application
    2.3.4.1 Global GLP-1 Analogues Sale Market Share by Application (2021-2026)
    2.3.4.2 Global GLP-1 Analogues Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global GLP-1 Analogues Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global GLP-1 Analogues Breakdown Data by Company
  3.1.1 Global GLP-1 Analogues Annual Sales by Company (2021-2026)
  3.1.2 Global GLP-1 Analogues Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 Analogues Annual Revenue by Company (2021-2026)
  3.2.1 Global GLP-1 Analogues Revenue by Company (2021-2026)
  3.2.2 Global GLP-1 Analogues Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 Analogues Sale Price by Company
3.4 Key Manufacturers GLP-1 Analogues Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers GLP-1 Analogues Product Location Distribution
  3.4.2 Players GLP-1 Analogues Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GLP-1 ANALOGUES BY GEOGRAPHIC REGION

4.1 World Historic GLP-1 Analogues Market Size by Geographic Region (2021-2026)
  4.1.1 Global GLP-1 Analogues Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global GLP-1 Analogues Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 Analogues Market Size by Country/Region (2021-2026)
  4.2.1 Global GLP-1 Analogues Annual Sales by Country/Region (2021-2026)
  4.2.2 Global GLP-1 Analogues Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 Analogues Sales Growth
4.4 APAC GLP-1 Analogues Sales Growth
4.5 Europe GLP-1 Analogues Sales Growth
4.6 Middle East & Africa GLP-1 Analogues Sales Growth

5 AMERICAS

5.1 Americas GLP-1 Analogues Sales by Country
  5.1.1 Americas GLP-1 Analogues Sales by Country (2021-2026)
  5.1.2 Americas GLP-1 Analogues Revenue by Country (2021-2026)
5.2 Americas GLP-1 Analogues Sales by Type (2021-2026)
5.3 Americas GLP-1 Analogues Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC GLP-1 Analogues Sales by Region
  6.1.1 APAC GLP-1 Analogues Sales by Region (2021-2026)
  6.1.2 APAC GLP-1 Analogues Revenue by Region (2021-2026)
6.2 APAC GLP-1 Analogues Sales by Type (2021-2026)
6.3 APAC GLP-1 Analogues Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe GLP-1 Analogues by Country
  7.1.1 Europe GLP-1 Analogues Sales by Country (2021-2026)
  7.1.2 Europe GLP-1 Analogues Revenue by Country (2021-2026)
7.2 Europe GLP-1 Analogues Sales by Type (2021-2026)
7.3 Europe GLP-1 Analogues Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa GLP-1 Analogues by Country
  8.1.1 Middle East & Africa GLP-1 Analogues Sales by Country (2021-2026)
  8.1.2 Middle East & Africa GLP-1 Analogues Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 Analogues Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 Analogues Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Analogues
10.3 Manufacturing Process Analysis of GLP-1 Analogues
10.4 Industry Chain Structure of GLP-1 Analogues

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 GLP-1 Analogues Distributors
11.3 GLP-1 Analogues Customer

12 WORLD FORECAST REVIEW FOR GLP-1 ANALOGUES BY GEOGRAPHIC REGION

12.1 Global GLP-1 Analogues Market Size Forecast by Region
  12.1.1 Global GLP-1 Analogues Forecast by Region (2027-2032)
  12.1.2 Global GLP-1 Analogues Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 Analogues Forecast by Type (2027-2032)
12.7 Global GLP-1 Analogues Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk GLP-1 Analogues Product Portfolios and Specifications
  13.1.3 Novo Nordisk GLP-1 Analogues Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Information
  13.2.2 AstraZeneca GLP-1 Analogues Product Portfolios and Specifications
  13.2.3 AstraZeneca GLP-1 Analogues Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 AstraZeneca Main Business Overview
  13.2.5 AstraZeneca Latest Developments
13.3 Eli Lily
  13.3.1 Eli Lily Company Information
  13.3.2 Eli Lily GLP-1 Analogues Product Portfolios and Specifications
  13.3.3 Eli Lily GLP-1 Analogues Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Eli Lily Main Business Overview
  13.3.5 Eli Lily Latest Developments
13.4 GSK
  13.4.1 GSK Company Information
  13.4.2 GSK GLP-1 Analogues Product Portfolios and Specifications
  13.4.3 GSK GLP-1 Analogues Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 GSK Main Business Overview
  13.4.5 GSK Latest Developments
13.5 Sanofi
  13.5.1 Sanofi Company Information
  13.5.2 Sanofi GLP-1 Analogues Product Portfolios and Specifications
  13.5.3 Sanofi GLP-1 Analogues Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Sanofi Main Business Overview
  13.5.5 Sanofi Latest Developments
13.6 Jiangsu Hansoh Pharmaceutical
  13.6.1 Jiangsu Hansoh Pharmaceutical Company Information
  13.6.2 Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Product Portfolios and Specifications
  13.6.3 Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Jiangsu Hansoh Pharmaceutical Main Business Overview
  13.6.5 Jiangsu Hansoh Pharmaceutical Latest Developments
13.7 Shanghai Benemae Pharmaceutical
  13.7.1 Shanghai Benemae Pharmaceutical Company Information
  13.7.2 Shanghai Benemae Pharmaceutical GLP-1 Analogues Product Portfolios and Specifications
  13.7.3 Shanghai Benemae Pharmaceutical GLP-1 Analogues Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Shanghai Benemae Pharmaceutical Main Business Overview
  13.7.5 Shanghai Benemae Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. GLP-1 Analogues Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 Analogues Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Exenatide
Table 4. Major Players of Liraglutide
Table 5. Major Players of Semaglutide
Table 6. Major Players of Dulaglutide
Table 7. Major Players of Other
Table 8. Global GLP-1 Analogues Sales by Type (2021-2026) & (K Units)
Table 9. Global GLP-1 Analogues Sales Market Share by Type (2021-2026)
Table 10. Global GLP-1 Analogues Revenue by Type (2021-2026) & ($ million)
Table 11. Global GLP-1 Analogues Revenue Market Share by Type (2021-2026)
Table 12. Global GLP-1 Analogues Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global GLP-1 Analogues Sale by Application (2021-2026) & (K Units)
Table 14. Global GLP-1 Analogues Sale Market Share by Application (2021-2026)
Table 15. Global GLP-1 Analogues Revenue by Application (2021-2026) & ($ million)
Table 16. Global GLP-1 Analogues Revenue Market Share by Application (2021-2026)
Table 17. Global GLP-1 Analogues Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global GLP-1 Analogues Sales by Company (2021-2026) & (K Units)
Table 19. Global GLP-1 Analogues Sales Market Share by Company (2021-2026)
Table 20. Global GLP-1 Analogues Revenue by Company (2021-2026) & ($ millions)
Table 21. Global GLP-1 Analogues Revenue Market Share by Company (2021-2026)
Table 22. Global GLP-1 Analogues Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers GLP-1 Analogues Producing Area Distribution and Sales Area
Table 24. Players GLP-1 Analogues Products Offered
Table 25. GLP-1 Analogues Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global GLP-1 Analogues Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global GLP-1 Analogues Sales Market Share Geographic Region (2021-2026)
Table 30. Global GLP-1 Analogues Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global GLP-1 Analogues Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global GLP-1 Analogues Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global GLP-1 Analogues Sales Market Share by Country/Region (2021-2026)
Table 34. Global GLP-1 Analogues Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global GLP-1 Analogues Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas GLP-1 Analogues Sales by Country (2021-2026) & (K Units)
Table 37. Americas GLP-1 Analogues Sales Market Share by Country (2021-2026)
Table 38. Americas GLP-1 Analogues Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas GLP-1 Analogues Sales by Type (2021-2026) & (K Units)
Table 40. Americas GLP-1 Analogues Sales by Application (2021-2026) & (K Units)
Table 41. APAC GLP-1 Analogues Sales by Region (2021-2026) & (K Units)
Table 42. APAC GLP-1 Analogues Sales Market Share by Region (2021-2026)
Table 43. APAC GLP-1 Analogues Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC GLP-1 Analogues Sales by Type (2021-2026) & (K Units)
Table 45. APAC GLP-1 Analogues Sales by Application (2021-2026) & (K Units)
Table 46. Europe GLP-1 Analogues Sales by Country (2021-2026) & (K Units)
Table 47. Europe GLP-1 Analogues Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe GLP-1 Analogues Sales by Type (2021-2026) & (K Units)
Table 49. Europe GLP-1 Analogues Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa GLP-1 Analogues Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa GLP-1 Analogues Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa GLP-1 Analogues Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa GLP-1 Analogues Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of GLP-1 Analogues
Table 55. Key Market Challenges & Risks of GLP-1 Analogues
Table 56. Key Industry Trends of GLP-1 Analogues
Table 57. GLP-1 Analogues Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. GLP-1 Analogues Distributors List
Table 60. GLP-1 Analogues Customer List
Table 61. Global GLP-1 Analogues Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global GLP-1 Analogues Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas GLP-1 Analogues Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas GLP-1 Analogues Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC GLP-1 Analogues Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC GLP-1 Analogues Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe GLP-1 Analogues Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe GLP-1 Analogues Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa GLP-1 Analogues Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa GLP-1 Analogues Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global GLP-1 Analogues Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global GLP-1 Analogues Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global GLP-1 Analogues Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global GLP-1 Analogues Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Novo Nordisk Basic Information, GLP-1 Analogues Manufacturing Base, Sales Area and Its Competitors
Table 76. Novo Nordisk GLP-1 Analogues Product Portfolios and Specifications
Table 77. Novo Nordisk GLP-1 Analogues Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Novo Nordisk Main Business
Table 79. Novo Nordisk Latest Developments
Table 80. AstraZeneca Basic Information, GLP-1 Analogues Manufacturing Base, Sales Area and Its Competitors
Table 81. AstraZeneca GLP-1 Analogues Product Portfolios and Specifications
Table 82. AstraZeneca GLP-1 Analogues Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Eli Lily Basic Information, GLP-1 Analogues Manufacturing Base, Sales Area and Its Competitors
Table 86. Eli Lily GLP-1 Analogues Product Portfolios and Specifications
Table 87. Eli Lily GLP-1 Analogues Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Eli Lily Main Business
Table 89. Eli Lily Latest Developments
Table 90. GSK Basic Information, GLP-1 Analogues Manufacturing Base, Sales Area and Its Competitors
Table 91. GSK GLP-1 Analogues Product Portfolios and Specifications
Table 92. GSK GLP-1 Analogues Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. GSK Main Business
Table 94. GSK Latest Developments
Table 95. Sanofi Basic Information, GLP-1 Analogues Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi GLP-1 Analogues Product Portfolios and Specifications
Table 97. Sanofi GLP-1 Analogues Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. Jiangsu Hansoh Pharmaceutical Basic Information, GLP-1 Analogues Manufacturing Base, Sales Area and Its Competitors
Table 101. Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Product Portfolios and Specifications
Table 102. Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Jiangsu Hansoh Pharmaceutical Main Business
Table 104. Jiangsu Hansoh Pharmaceutical Latest Developments
Table 105. Shanghai Benemae Pharmaceutical Basic Information, GLP-1 Analogues Manufacturing Base, Sales Area and Its Competitors
Table 106. Shanghai Benemae Pharmaceutical GLP-1 Analogues Product Portfolios and Specifications
Table 107. Shanghai Benemae Pharmaceutical GLP-1 Analogues Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Shanghai Benemae Pharmaceutical Main Business
Table 109. Shanghai Benemae Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of GLP-1 Analogues
Figure 2. GLP-1 Analogues Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Analogues Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global GLP-1 Analogues Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 Analogues Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 Analogues Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 Analogues Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Exenatide
Figure 12. Product Picture of Liraglutide
Figure 13. Product Picture of Semaglutide
Figure 14. Product Picture of Dulaglutide
Figure 15. Product Picture of Other
Figure 16. Global GLP-1 Analogues Sales Market Share by Type in 2026
Figure 17. Global GLP-1 Analogues Revenue Market Share by Type (2021-2026)
Figure 18. GLP-1 Analogues Consumed in Hospital
Figure 19. Global GLP-1 Analogues Market: Hospital (2021-2026) & (K Units)
Figure 20. GLP-1 Analogues Consumed in Clinic
Figure 21. Global GLP-1 Analogues Market: Clinic (2021-2026) & (K Units)
Figure 22. GLP-1 Analogues Consumed in Other
Figure 23. Global GLP-1 Analogues Market: Other (2021-2026) & (K Units)
Figure 24. Global GLP-1 Analogues Sale Market Share by Application (2025)
Figure 25. Global GLP-1 Analogues Revenue Market Share by Application in 2026
Figure 26. GLP-1 Analogues Sales by Company in 2026 (K Units)
Figure 27. Global GLP-1 Analogues Sales Market Share by Company in 2026
Figure 28. GLP-1 Analogues Revenue by Company in 2026 ($ millions)
Figure 29. Global GLP-1 Analogues Revenue Market Share by Company in 2026
Figure 30. Global GLP-1 Analogues Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global GLP-1 Analogues Revenue Market Share by Geographic Region in 2026
Figure 32. Americas GLP-1 Analogues Sales 2021-2026 (K Units)
Figure 33. Americas GLP-1 Analogues Revenue 2021-2026 ($ millions)
Figure 34. APAC GLP-1 Analogues Sales 2021-2026 (K Units)
Figure 35. APAC GLP-1 Analogues Revenue 2021-2026 ($ millions)
Figure 36. Europe GLP-1 Analogues Sales 2021-2026 (K Units)
Figure 37. Europe GLP-1 Analogues Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa GLP-1 Analogues Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa GLP-1 Analogues Revenue 2021-2026 ($ millions)
Figure 40. Americas GLP-1 Analogues Sales Market Share by Country in 2026
Figure 41. Americas GLP-1 Analogues Revenue Market Share by Country (2021-2026)
Figure 42. Americas GLP-1 Analogues Sales Market Share by Type (2021-2026)
Figure 43. Americas GLP-1 Analogues Sales Market Share by Application (2021-2026)
Figure 44. United States GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC GLP-1 Analogues Sales Market Share by Region in 2026
Figure 49. APAC GLP-1 Analogues Revenue Market Share by Region (2021-2026)
Figure 50. APAC GLP-1 Analogues Sales Market Share by Type (2021-2026)
Figure 51. APAC GLP-1 Analogues Sales Market Share by Application (2021-2026)
Figure 52. China GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 56. India GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe GLP-1 Analogues Sales Market Share by Country in 2026
Figure 60. Europe GLP-1 Analogues Revenue Market Share by Country (2021-2026)
Figure 61. Europe GLP-1 Analogues Sales Market Share by Type (2021-2026)
Figure 62. Europe GLP-1 Analogues Sales Market Share by Application (2021-2026)
Figure 63. Germany GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 64. France GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 65. UK GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa GLP-1 Analogues Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa GLP-1 Analogues Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa GLP-1 Analogues Sales Market Share by Application (2021-2026)
Figure 71. Egypt GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries GLP-1 Analogues Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of GLP-1 Analogues in 2026
Figure 77. Manufacturing Process Analysis of GLP-1 Analogues
Figure 78. Industry Chain Structure of GLP-1 Analogues
Figure 79. Channels of Distribution
Figure 80. Global GLP-1 Analogues Sales Market Forecast by Region (2027-2032)
Figure 81. Global GLP-1 Analogues Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global GLP-1 Analogues Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global GLP-1 Analogues Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global GLP-1 Analogues Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global GLP-1 Analogues Revenue Market Share Forecast by Application (2027-2032)